Lichen Planus Induced by Pegylated Interferon Alfa-2a Therapy in a Patient Monitored for Delta Hepatitis
Interferons are used for treatment of chronic hepatitis B. They can induce or exacerbate some skin disorders, such as lichen planus. In this study, as we know, we presented the first case developing lichen planus while receiving interferon treatment due to delta hepatitis. A 31-year-old male patient...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2015/389131 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832554088324136960 |
|---|---|
| author | Safak Kaya Eyup Arslan Birol Baysal Sule Nergiz Baykara Ozlem Ceren Uzun Sehmuz Kaya |
| author_facet | Safak Kaya Eyup Arslan Birol Baysal Sule Nergiz Baykara Ozlem Ceren Uzun Sehmuz Kaya |
| author_sort | Safak Kaya |
| collection | DOAJ |
| description | Interferons are used for treatment of chronic hepatitis B. They can induce or exacerbate some skin disorders, such as lichen planus. In this study, as we know, we presented the first case developing lichen planus while receiving interferon treatment due to delta hepatitis. A 31-year-old male patient presented to our outpatient clinic with HBsAg positivity. With his analyses, HBV DNA was negative, anti-delta total was positive, ALT was 72 U/L (upper limit 41 U/L), and platelet was 119 000/mm3. He was therefore started on subcutaneous pegylated interferon alfa-2a therapy at 180 mcg/week for delta hepatitis. At month 4 of therapy, the patient developed diffuse eroded lace-like lesions in oral mucosa, white plaques on lips, and itchy papular lesions in the hands and feet. Lichen planus was considered by the dermatology clinic and topical treatment (mometasone furoate) was given. The lesions persisted at month 5 of therapy and biopsy samples were obtained from oral mucosal lesions and interferon dose was reduced to 135 mcg/week. Biopsy demonstrated nonkeratinized stratified squamous epithelium; epithelial acanthosis, spongiosis, and apoptotic bodies were observed in the epidermis and therefore lichen planus was considered. At month 6 of therapy, lesions did not improve and even progressed and interferon treatment was therefore discontinued. |
| format | Article |
| id | doaj-art-66349eb149cf41b4b41ee8a705cf40b3 |
| institution | Kabale University |
| issn | 2090-6625 2090-6633 |
| language | English |
| publishDate | 2015-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Infectious Diseases |
| spelling | doaj-art-66349eb149cf41b4b41ee8a705cf40b32025-02-03T05:52:19ZengWileyCase Reports in Infectious Diseases2090-66252090-66332015-01-01201510.1155/2015/389131389131Lichen Planus Induced by Pegylated Interferon Alfa-2a Therapy in a Patient Monitored for Delta HepatitisSafak Kaya0Eyup Arslan1Birol Baysal2Sule Nergiz Baykara3Ozlem Ceren Uzun4Sehmuz Kaya5Department of Infectious Diseases, Gazi Yasargil Training and Research Hospital, TurkeyDepartment of Infectious Diseases, Selahaddin Eyyubi State Hospital, TurkeyDepartment of Gastroenterology, Bezmialem University Faculty of Medicine, TurkeyDepartment of Dermatology, Selahaddin Eyyubi State Hospital, TurkeyDepartment of Pathology, Selahaddin Eyyubi State Hospital, TurkeyDepartment of Orthopedics Surgery, Van Training and Research Hospital, TurkeyInterferons are used for treatment of chronic hepatitis B. They can induce or exacerbate some skin disorders, such as lichen planus. In this study, as we know, we presented the first case developing lichen planus while receiving interferon treatment due to delta hepatitis. A 31-year-old male patient presented to our outpatient clinic with HBsAg positivity. With his analyses, HBV DNA was negative, anti-delta total was positive, ALT was 72 U/L (upper limit 41 U/L), and platelet was 119 000/mm3. He was therefore started on subcutaneous pegylated interferon alfa-2a therapy at 180 mcg/week for delta hepatitis. At month 4 of therapy, the patient developed diffuse eroded lace-like lesions in oral mucosa, white plaques on lips, and itchy papular lesions in the hands and feet. Lichen planus was considered by the dermatology clinic and topical treatment (mometasone furoate) was given. The lesions persisted at month 5 of therapy and biopsy samples were obtained from oral mucosal lesions and interferon dose was reduced to 135 mcg/week. Biopsy demonstrated nonkeratinized stratified squamous epithelium; epithelial acanthosis, spongiosis, and apoptotic bodies were observed in the epidermis and therefore lichen planus was considered. At month 6 of therapy, lesions did not improve and even progressed and interferon treatment was therefore discontinued.http://dx.doi.org/10.1155/2015/389131 |
| spellingShingle | Safak Kaya Eyup Arslan Birol Baysal Sule Nergiz Baykara Ozlem Ceren Uzun Sehmuz Kaya Lichen Planus Induced by Pegylated Interferon Alfa-2a Therapy in a Patient Monitored for Delta Hepatitis Case Reports in Infectious Diseases |
| title | Lichen Planus Induced by Pegylated Interferon Alfa-2a Therapy in a Patient Monitored for Delta Hepatitis |
| title_full | Lichen Planus Induced by Pegylated Interferon Alfa-2a Therapy in a Patient Monitored for Delta Hepatitis |
| title_fullStr | Lichen Planus Induced by Pegylated Interferon Alfa-2a Therapy in a Patient Monitored for Delta Hepatitis |
| title_full_unstemmed | Lichen Planus Induced by Pegylated Interferon Alfa-2a Therapy in a Patient Monitored for Delta Hepatitis |
| title_short | Lichen Planus Induced by Pegylated Interferon Alfa-2a Therapy in a Patient Monitored for Delta Hepatitis |
| title_sort | lichen planus induced by pegylated interferon alfa 2a therapy in a patient monitored for delta hepatitis |
| url | http://dx.doi.org/10.1155/2015/389131 |
| work_keys_str_mv | AT safakkaya lichenplanusinducedbypegylatedinterferonalfa2atherapyinapatientmonitoredfordeltahepatitis AT eyuparslan lichenplanusinducedbypegylatedinterferonalfa2atherapyinapatientmonitoredfordeltahepatitis AT birolbaysal lichenplanusinducedbypegylatedinterferonalfa2atherapyinapatientmonitoredfordeltahepatitis AT sulenergizbaykara lichenplanusinducedbypegylatedinterferonalfa2atherapyinapatientmonitoredfordeltahepatitis AT ozlemcerenuzun lichenplanusinducedbypegylatedinterferonalfa2atherapyinapatientmonitoredfordeltahepatitis AT sehmuzkaya lichenplanusinducedbypegylatedinterferonalfa2atherapyinapatientmonitoredfordeltahepatitis |